Novo Nordisk
NVO
#22
Rank
C$569.25 B
Marketcap
$122.13
Share price
-17.83%
Change (1 day)
-11.15%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2024 (TTM): C$24.09 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are C$39.69 Billion. In 2023 the company made an earning of C$22.16 Billion, an increase over its 2022 earnings that were of C$14.06 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$24.09 B8.71%
2023 C$22.16 B57.64%
2022 C$14.06 B5.35%
2021 C$13.34 B12.47%
2020 C$11.86 B13.07%
2019 C$10.49 B-3.35%
2018 C$10.86 B1.79%
2017 C$10.66 B4.52%
2016 C$10.20 B9.42%
2015 C$9.32 B8.24%
2014 C$8.61 B3.45%
2013 C$8.33 B19.02%
2012 C$7.00 B15.21%
2011 C$6.07 B17.71%
2010 C$5.16 B24.78%
2009 C$4.13 B10.62%
2008 C$3.73 B55.97%
2007 C$2.39 B7.07%
2006 C$2.23 B18.18%
2005 C$1.89 B11.33%
2004 C$1.70 B
2002 C$1.06 B-14.39%
2001 C$1.23 B-52.82%
2000 C$2.62 B250%
1999 C$0.75 B31.21%
1998 C$0.57 B34.31%
1997 C$0.42 B11.46%
1996 C$0.38 B9.03%
1995 C$0.35 B-3.15%
1994 C$0.36 B-0.67%
1993 C$0.36 B45.38%
1992 C$0.25 B-13.81%
1991 C$0.29 B37.12%
1990 C$0.21 B-0.79%
1989 C$0.21 B26.2%
1988 C$0.16 B24.97%
1987 C$0.13 B-0.9%
1986 C$0.13 B-7.78%
1985 C$0.14 B24.87%
1984 C$0.11 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$9.97 B-61.09%๐Ÿ‡บ๐Ÿ‡ธ USA
C$14.58 B-43.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$9.89 Billion-138.56%๐Ÿ‡บ๐Ÿ‡ธ USA
C$10.64 B-58.48%๐Ÿ‡ซ๐Ÿ‡ท France